Site Reference ID/Investigator# 5469 — Birmingham, Alabama

Site Reference ID/Investigator# 5469 is a clinical research site located in Birmingham, Alabama, United States 35205.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 5469 has participated in 1 clinical trials.

Therapeutic areas: Hypercholesterolemia, Dyslipidemia.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 5469?

Site Reference ID/Investigator# 5469 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 5469 conducted?

Site Reference ID/Investigator# 5469 has 1 clinical trials on record. Their work covers Hypercholesterolemia, Dyslipidemia.

Is Site Reference ID/Investigator# 5469 accredited by Crixeo Health?

Site Reference ID/Investigator# 5469 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 5469?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.